Imene Becheker
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Imene Becheker has a total of 3 co-authors. Here are the top co-authors by number of shared publications:
- Mohamed Akram Melakhessou
University of Batna2, Algeria
2 shared publications - Nadia Khater
University of Batna2, Algeria
2 shared publications - Salah Eddine Marref
Department of Organismal Biology, Faculty of Nature and Life Sciences, Mustefa Ben Boulaïd Batna 2 University Laboratory of Biotechnology of Bioactive Molecules and Cellular Pathophysiology (LBMBPC), University of Batna 2, Algeria
2 shared publications
Latest Publications
- 19 October 2026
- Published by Elsevier in Bulletin de l'Académie Nationale de Médecine
- Vol. 210 (9) , 1037-1046
Vaccins anticancéreux personnalisés à néoantigènes : fondements, données cliniques et enjeux pratiques
- 19 October 2026
- Published by Elsevier in Bulletin de l'Académie Nationale de Médecine
- Vol. 210 (9) , 1037-1046
Vaccins anticancéreux personnalisés à néoantigènes : fondements, données cliniques et enjeux pratiques
- Open Access
- 1 January 2026
- Published by National Library of Serbia in Archives of Biological Sciences
- Vol. 78 (2) , 131-141
Optimized Teucrium polium topical cream improves wound closure in a rat excisional model: A D-optimal design and RBF modelling approach
Chronic wounds require topical formulations that combine favorable physicochemical properties with measurable biological activity. In this study, a bio-based, oil-in-water cream containing Teucrium polium methanolic extract was developed and optimized using a D-optimal design and a radial basis function (RBF) modeling approach. Three formulation variables, extract content (X1), cetyl alcohol (X2), and shea butter (X3), were evaluated in relation to two responses: spreadability (Y1) and wound closure on Day 7 (Y2). Predictive modeling was performed using an RBF network with leave-one-out cross-validation (LOOCV), which provided an internal estimate of predictive performance (R2 training = 0.98-0.99; R2 test = 0.95-0.96). Multi-response optimization identified an optimal formulation containing 8.0% extract, 1.5% cetyl alcohol, and 1.0% shea butter. Experimental confirmation yielded a spreadability of 54.8±0.9 cm2 and 84.1±1.2% wound closure on Day 7. In the confirmatory in vivo comparison, a vehicle control, a positive control (Madecassol 1%), and selected formulations were followed through Day 14. F6, F11, and F18 showed the most favorable macroscopic woundclosure profiles, whereas F2 displayed a more moderate effect. These findings support the use of a multivariate optimization strategy for the rational development of bio-based topical creams, while the biological interpretation remains limited to wound closure under the tested conditions.
- 1 January 2026
- Published by National Library of Serbia in Archives of Biological Sciences
- Vol. 78 (2) , 131-141
Open AccessOptimized Teucrium polium topical cream improves wound closure in a rat excisional model: A D-optimal design and RBF modelling approach
Chronic wounds require topical formulations that combine favorable physicochemical properties with measurable biological activity. In this study, a bio-based, oil-in-water cream containing Teucrium polium methanolic extract was developed and optimized using a D-optimal design and a radial basis function (RBF) modeling approach. Three formulation variables, extract content (X1), cetyl alcohol (X2), and shea butter (X3), were evaluated in relation to two responses: spreadability (Y1) and wound closure on Day 7 (Y2). Predictive modeling was performed using an RBF network with leave-one-out cross-validation (LOOCV), which provided an internal estimate of predictive performance (R2 training = 0.98-0.99; R2 test = 0.95-0.96). Multi-response optimization identified an optimal formulation containing 8.0% extract, 1.5% cetyl alcohol, and 1.0% shea butter. Experimental confirmation yielded a spreadability of 54.8±0.9 cm2 and 84.1±1.2% wound closure on Day 7. In the confirmatory in vivo comparison, a vehicle control, a positive control (Madecassol 1%), and selected formulations were followed through Day 14. F6, F11, and F18 showed the most favorable macroscopic woundclosure profiles, whereas F2 displayed a more moderate effect. These findings support the use of a multivariate optimization strategy for the rational development of bio-based topical creams, while the biological interpretation remains limited to wound closure under the tested conditions.